In a randomized trial, one donor-feces infusion cured 81% of recurrent C. difficile infections versus 31% with vancomycin alone; FMT is approved for this infection, not for aging.
Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).